Cargando…
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Oestrogen receptor-α (ER) is the defining and driving transcription factor in the majority of breast cancers and its target genes dictate cell growth and endocrine response, yet genomic understanding of ER function has been restricted to model systems(1-3). We now map genome-wide ER binding events,...
Autores principales: | Ross-Innes, Caryn S., Stark, Rory, Teschendorff, Andrew E., Holmes, Kelly A., Ali, H. Raza, Dunning, Mark J., Brown, Gordon D., Gojis, Ondrej, Ellis, Ian O., Green, Andrew R., Ali, Simak, Chin, Suet-Feung, Palmieri, Carlo, Caldas, Carlos, Carroll, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272464/ https://www.ncbi.nlm.nih.gov/pubmed/22217937 http://dx.doi.org/10.1038/nature10730 |
Ejemplares similares
-
Genome-driven integrated classification of breast cancer validated in over 7,500 samples
por: Ali, H Raza, et al.
Publicado: (2014) -
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
por: Blenkiron, Cherie, et al.
Publicado: (2007) -
Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer
por: Meyer, Kerstin B, et al.
Publicado: (2008) -
Calling Sample Mix-Ups in Cancer Population Studies
por: Lynch, Andy G., et al.
Publicado: (2012) -
Breast tumor microenvironment structures are associated with genomic features and clinical outcome
por: Danenberg, Esther, et al.
Publicado: (2022)